Bio-Path Holdings, Inc.
BPTH
$0.03
-$0.01-19.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 259.00K | 41.00K | 213.00K | 514.00K | 1.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 297.00K | 41.00K | 488.00K | 4.56M | 3.24M |
| Operating Income | -297.00K | -41.00K | -488.00K | -4.56M | -3.24M |
| Income Before Tax | -270.00K | -249.00K | -976.00K | -4.60M | -2.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -270.00K | -249.00K | -976.00K | -4.60M | -2.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -270.00K | -249.00K | -976.00K | -4.60M | -2.85M |
| EBIT | -297.00K | -41.00K | -488.00K | -4.56M | -3.24M |
| EBITDA | -291.30K | -41.00K | -479.00K | -4.55M | -3.24M |
| EPS Basic | -0.03 | -0.03 | -0.11 | -0.55 | -0.40 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.07 | -0.35 | -0.25 |
| EPS Diluted | -0.03 | -0.03 | -0.11 | -0.55 | -0.40 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.07 | -0.35 | -0.25 |
| Average Basic Shares Outstanding | 9.34M | 7.91M | 8.52M | 8.31M | 7.06M |
| Average Diluted Shares Outstanding | 9.34M | 7.91M | 8.52M | 8.31M | 7.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |